PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Clinical trials for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Why are PAH patients waiting too long for a diagnosis?
Knowledge-focused Recruiting nowThis study looks at how long it takes for people with pulmonary arterial hypertension (PAH) to get a correct diagnosis after their first symptoms appear. Researchers will review medical records from 139 adults in Brazil to find out what causes delays, such as seeing many differen…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: University of Sao Paulo General Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 13:01 UTC
-
PAH drug switch under the microscope: will patients benefit?
Knowledge-focused Recruiting nowThis study looks at what happens when people with pulmonary arterial hypertension (PAH) switch from one medication (ambrisentan) to another (bosentan). Researchers will track 121 adults to see if their risk scores improve, worsen, or stay the same 3 to 6 months after the switch. …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: University of Sao Paulo General Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 12:58 UTC
-
Can your genes predict lung disease? 10,000-Person study seeks answers
Knowledge-focused Recruiting nowThis study looks at how genes influence the risk of pulmonary hypertension, a serious lung condition. Researchers aim to enroll 10,000 adults in the US, with or without the disease. Participants complete online health surveys and provide a saliva sample by mail. The goal is to fi…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
New tool aims to gauge patient understanding of rare lung disease
Knowledge-focused Recruiting nowThis study is creating and testing a questionnaire to see how much people with pulmonary arterial hypertension (PAH) know about their condition. Researchers will check if the questions make sense to patients and experts. Up to 200 adults with PAH will take part. The goal is to ha…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: NA • Sponsor: University of Sao Paulo General Hospital • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:15 UTC